- $103.11m
- $76.11m
- $240.68m
- 48
- 99
- 13
- 52
Annual income statement for Citizens, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | R2021 December 31st | R2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Total Premiums Earned | |||||
| Net Investment Income | |||||
| Realized & Unrealized Gains / Losses | |||||
| Total Revenue | 251 | 239 | 251 | 233 | 241 |
| Losses, Benefits, and Adjustments | |||||
| Amortization of Policy Acquisition Costs | |||||
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 245 | 251 | 220 | 205 | 215 |
| Operating Profit | 5.75 | -12.3 | 30.5 | 27.4 | 26.2 |
| Net Income Before Taxes | 5.75 | -12.3 | 30.5 | 27.4 | 26.2 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -1.37 | -11 | 72.7 | 26 | 24.4 |
| Net Income Before Extraordinary Items | |||||
| Extraordinary Items | |||||
| Net Income | -1.37 | -11 | 72.7 | 26 | 24.4 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -1.37 | -11 | 72.7 | 26 | 24.4 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.027 | -0.218 | 1.6 | 0.511 | 0.482 |